ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo

Journal of Experimental Medicine

Volumn 207, Issue 3, 2010, Pages 623-635

  Gibb, David R ^a   El Shikh, Mohey ^a   Kang, Dae Joong ^a   Rowe, Warren J ^a   El Sayed, Rania ^a   Cichy, Joanna ^b   Yagita, Hideo ^c   Tew, John G ^a   Dempsey, Peter J ^d   Crawford, Howard C ^e   Conrad, Daniel H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; CD23 ANTIGEN; DISINTEGRIN; IMMUNOGLOBULIN E RECEPTOR; METALLOPROTEINASE; NOTCH2 RECEPTOR; REGULATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CELL FATE; CELL MATURATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DROSOPHILA; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; B-LYMPHOCYTES; DNA, COMPLEMENTARY; EXONS; GENE AMPLIFICATION; GENE DELETION; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; RECEPTOR, NOTCH2; RECEPTORS, CCR1; RECEPTORS, IGE; RECOMBINATION, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPLEEN; T-LYMPHOCYTES;

EID: 77949528417     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20091990     Document Type: Article

References (56)

1. Black, R.A., and J.M. White. 1998. ADAMs: focus on the protease domain. Curr. Opin. Cell Biol. 10:654-659. doi:10.1016/S0955-0674(98)80042-2
2. Blobel, C.P. 2005. ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 6:32-43. doi:10.1038/nrm1548
3. Bozkulak, E.C., and G. Weinmaster. 2009. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Mol. Cell. Biol. 29:5679-5695. doi:10.1128/MCB.00406-09
4. Brou, C., F. Logeat, N. Gupta, C. Bessia, O. LeBail, J.R. Doedens, A. Cumano, P. Roux, R.A. Black, and A. Israël. 2000. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin- metalloprotease TACE. Mol. Cell. 5:207-216. doi:10.1016/S1097-2765(00) 80417-7
5. Cinamon, G., M.A. Zachariah, O.M. Lam, F.W. Foss Jr., and J.G. Cyster. 2008. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol. 9:54-62. doi:10.1038/ni1542
6. Conrad, D.H., J.W. Ford, J.L. Sturgill, and D.R. Gibb. 2007. CD23: an overlooked regulator of allergic disease. Curr. Allergy Asthma Rep. 7:331-337. doi:10.1007/s11882-007-0050-y
7. Contin, C., V. Pitard, T. Itai, S. Nagata, J.F. Moreau, and J. Déchanet-Merville. 2003. Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling. J. Biol. Chem. 278:32801-32809. doi:10.1074/jbc.M209993200
8. Crawford, H.C., P.J. Dempsey, G. Brown, L. Adam, and M.L. Moss. 2009. ADAM10 as a therapeutic target for cancer and inflammation. Curr. Pharm. Des. 15:2288-2299. doi:10.2174/138161209788682442
9. Croix, D.A., J.M. Ahearn, A.M. Rosengard, S. Han, G. Kelsoe, M. Ma, and M.C. Carroll. 1996. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183:1857-1864. doi:10.1084/jem.183.4.1857
10. Ford, J.W., M.A. Kilmon, K.M. Haas, A.E. Shelburne, Y. Chan-Li, and D.H. Conrad. 2006. In vivo murine CD23 destabilization enhances CD23 shedding and IgE synthesis. Cell. Immunol. 243:107-117. doi:10.1016/j.cellimm.2007.01.004
11. Fourie, A.M., F. Coles, V. Moreno, and L. Karlsson. 2003. Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J. Biol. Chem. 278:30469-30477. doi:10.1074/jbc.M213157200
12. Gould, H.J., and B.J. Sutton. 2008. IgE in allergy and asthma today. Nat. Rev. Immunol. 8:205-217. doi:10.1038/nri2273
13. Hamada, Y., Y. Kadokawa, M. Okabe, M. Ikawa, J.R. Coleman, and Y. Tsujimoto. 1999. Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality. Development. 126:3415-3424.
14. Hartmann, D., B. de Strooper, L. Serneels, K. Craessaerts, A. Herreman, W. Annaert, L. Umans, T. Lübke, A. Lena Illert, K. von Figura, and P. Saftig. 2002. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum. Mol. Genet. 11:2615-2624. doi:10.1093/hmg/11.21.2615
15. Hinkle, C.L., S.W. Sunnarborg, D. Loiselle, C.E. Parker, M. Stevenson, W.E. Russell, and D.C. Lee. 2004. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. J. Biol. Chem. 279:24179-24188. doi:10.1074/jbc.M312141200
16. Hjelm, F., M.C. Karlsson, and B. Heyman. 2008. A novel B cell-mediated transport of IgE-immune complexes to the follicle of the spleen. J. Immunol. 180:6604-6610.
17. Hoefer, M.M., A. Aichem, A.M. Knight, and H. Illges. 2008. Modulation of murine complement receptor type 2 (CR2/CD21) ectodomain shedding by its cytoplasmic domain. Mol. Immunol. 45:2127-2137. doi:10.1016/j.molimm. 2007.12.015
18. Hozumi, K., N. Negishi, D. Suzuki, N. Abe, Y. Sotomaru, N. Tamaoki, C. Mailhos, D. Ish-Horowicz, S. Habu, and M.J. Owen. 2004. Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo. Nat. Immunol. 5:638-644. doi:10.1038/ni1075
19. Jackson, L., C.T. Cady, and J.C. Cambier. 2009. TLR4-mediated signaling induces MMP9-dependent cleavage of B cell surface CD23. J. Immunol. 183:2585-2592. doi:10.4049/jimmunol.0803660
20. Kelly, A.E., B.-H. Chen, E.C. Woodward, and D.H. Conrad. 1998. Production of a chimeric form of CD23 that is oligomeric and blocks IgE binding to the Fc epsilonRI. J. Immunol. 161:6696-6704.
21. Kilmon, M.A., A.E. Shelburne, Y. Chan-Li, K.L. Holmes, and D.H. Conrad. 2004. CD23 trimers are preassociated on the cell surface even in the absence of its ligand, IgE. J. Immunol. 172:1065-1073.
22. Kopan, R., and M.X. Ilagan. 2009. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 137:216-233. doi:10.1016/j.cell.2009.03.045
23. Lecoanet-Henchoz, S., J.-F. Gauchat, J.-P. Aubry, P. Graber, P. Life, N. Paul-Eugene, B. Ferrua, A.L. Corbi, B. Dugas, C. Plater-Zyberk, and J.-Y. Bonnefoy. 1995. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity. 3:119-125. doi:10.1016/1074-7613(95)90164-7
24. Lee, S.Y., K. Kumano, K. Nakazaki, M. Sanada, A. Matsumoto, G. Yamamoto, Y. Nannya, R. Suzuki, S. Ota, Y. Ota, et al. 2009. Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma. Cancer Sci. 100:920-926. doi:10.1111/j.1349-7006.2009.01130.x
25. Le Gall, S.M., P. Bobe, K. Reiss, K. Horiuchi, X.D. Niu, D. Lundell, D.R. Gibb, D. Conrad, P. Saftig, and C.P. Blobel. 2009. ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. Mol. Biol. Cell. 20:1785-1794. doi:10.1091/mbc.E08-11-1135
26. Lemieux, G.A., F. Blumenkron, N. Yeung, P. Zhou, J. Williams, A.C. Grammer, R. Petrovich, P.E. Lipsky, M.L. Moss, and Z. Werb. 2007. The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J. Biol. Chem. 282:14836-14844. doi:10.1074/jbc.M608414200
27. Li, N., K. Boyd, P.J. Dempsey, and D.A. Vignali. 2007. Non-cell autonomous expression of TNF-alpha-converting enzyme ADAM17 is required for normal lymphocyte development. J. Immunol. 178:4214-4221.
28. Makar, K.W., D. Ulgiati, J. Hagman, and V.M. Holers. 2001. A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation. Int. Immunol. 13:657-664. doi:10.1093/intimm/13.5.657
29. Manilay, J.O., A.C. Anderson, C. Kang, and E.A. Robey. 2005. Impairment of thymocyte development by dominant-negative Kuzbanian (ADAM-10) is rescued by the Notch ligand, delta-1. J. Immunol. 174:6732-6741.
30. Moran, S.T., A. Cariappa, H. Liu, B. Muir, D. Sgroi, C. Boboila, and S. Pillai. 2007. Synergism between NF-kappa B1/p50 and Notch2 during the development of marginal zone B lymphocytes. J. Immunol. 179:195-200.
31. Moriyama, Y., C. Sekine, A. Koyanagi, N. Koyama, H. Ogata, S. Chiba, S. Hirose, K. Okumura, and H. Yagita. 2008. Delta-like 1 is essential for the maintenance of marginal zone B cells in normal mice but not in autoimmune mice. Int. Immunol. 20:763-773. doi:10.1093/intimm/dxn034
32. Mumm, J.S., E.H. Schroeter, M.T. Saxena, A. Griesemer, X. Tian, D.J. Pan, W.J. Ray, and R. Kopan. 2000. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol. Cell. 5:197-206. doi:10.1016/S1097-2765(00)80416-5
33. Payet, M.E., E.C. Woodward, and D.H. Conrad. 1999. Humoral response suppression observed with CD23 transgenics. J. Immunol. 163:217-223.
34. Pillai, S., A. Cariappa, and S.T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23:161-196. doi:10.1146/annurev.immunol.23.021704. 115728
35. Radtke, F., A. Wilson, S.J. Mancini, and H.R. MacDonald. 2004. Notch regulation of lymphocyte development and function. Nat. Immunol. 5:247-253. doi:10.1038/ni1045
36. Ribbens, C., V. Bonnet, M.J. Kaiser, B. Andre, O. Kaye, N. Franchimont, D. de Groote, Y. Beguin, and M.G. Malaise. 2000. Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA). Clin. Exp. Immunol. 120:194-199. doi:10.1046/j.1365-2249.2000. 01198.x
37. Rickert, R.C., J. Roes, and K. Rajewsky. 1997. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25:1317-1318. doi:10.1093/nar/25.6.1317
38. Rosati, E., R. Sabatini, G. Rampino, A. Tabilio, M. Di Ianni, K. Fettucciari, A. Bartoli, S. Coaccioli, I. Screpanti, and P. Marconi. 2009. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood. 113:856-865. doi:10.1182/blood-2008-02- 139725
39. Sahin, U., G. Weskamp, K. Kelly, H.M. Zhou, S. Higashiyama, J. Peschon, D. Hartmann, P. Saftig, and C.P. Blobel. 2004. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164:769-779. doi:10.1083/jcb.200307137
40. Saito, T., S. Chiba, M. Ichikawa, A. Kunisato, T. Asai, K. Shimizu, T. Yamaguchi, G. Yamamoto, S. Seo, K. Kumano, et al. 2003. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity. 18:675-685. doi:10.1016/S1074-7613(03)00111-0
41. Santos, M.A., L.M. Sarmento, M. Rebelo, A.A. Doce, I. Maillard, A. Dumortier, H. Neves, F. Radtke, W.S. Pear, L. Parreira, and J. Demengeot. 2007. Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells. Proc. Natl. Acad. Sci. USA. 104:15454-15459. doi:10.1073/pnas.0702891104
42. Sarfati, M., S. Chevret, C. Chastang, G. Biron, P. Stryckmans, G. Delespesse, J.L. Binet, H. Merle-Beral, and D. Bron. 1996. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood. 88:4259-4264.
43. Schulte, M., K. Reiss, M. Lettau, T. Maretzky, A. Ludwig, D. Hartmann, B. de Strooper, O. Janssen, and P. Saftig. 2007. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ. 14:1040-1049.
44. Srinivas, S., T. Watanabe, C.S. Lin, C.M. William, Y. Tanabe, T.M. Jessell, and F. Costantini. 2001. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1:4. doi:10.1186/1471-213X-1-4
45. Strobl, L.J., H. Höfelmayr, G. Marschall, M. Brielmeier, G.W. Bornkamm, and U. Zimber-Strobl. 2000. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. J. Virol. 74:1727-1735. doi:10.1128/JVI.74.4.1727-1735.2000
46. Swiatek, P.J., C.E. Lindsell, F.F. del Amo, G. Weinmaster, and T. Gridley. 1994. Notch1 is essential for postimplantation development in mice. Genes Dev. 8:707-719. doi:10.1101/gad.8.6.707
47. Tanigaki, K., and T. Honjo. 2007. Regulation of lymphocyte development by Notch signaling. Nat. Immunol. 8:451-456. doi:10.1038/ni1453
48. Tanigaki, K., H. Han, N. Yamamoto, K. Tashiro, M. Ikegawa, K. Kuroda, A. Suzuki, T. Nakano, and T. Honjo. 2002. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3:443-450. doi:10.1038/ni793
49. Thomas, M., M. Calamito, B. Srivastava, I. Maillard, W.S. Pear, and D. Allman. 2007. Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation. Blood. 109:3342-3350. doi:10.1182/blood- 2006-09-046698
50. Tian, L., X. Wu, C. Chi, M. Han, T. Xu, and Y. Zhuang. 2008. ADAM10 is essential for proteolytic activation of Notch during thymocyte development. Int. Immunol. 20:1181-1187. doi:10.1093/intimm/dxn076
51. Troen, G., I. Wlodarska, A. Warsame, S. Hernández Llodrà, C. De Wolf-Peeters, and J. Delabie. 2008. NOTCH2 mutations in marginal zone lymphoma. Haematologica. 93:1107-1109. doi:10.3324/haematol.11635
52. van Tetering, G., P. van Diest, I. Verlaan, E. van der Wall, R. Kopan, and M. Vooijs. 2009. Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. J. Biol. Chem. 284:31018-31027. doi:10.1074/jbc.M109.006775
53. Weskamp, G., J.W. Ford, J. Sturgill, S. Martin, A.J. Docherty, S. Swendeman, N. Broadway, D. Hartmann, P. Saftig, S. Umland, et al. 2006. ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat. Immunol. 7:1293-1298. doi:10.1038/ni1399
54. Wolfer, A., A. Wilson, M. Nemir, H.R. MacDonald, and F. Radtke. 2002. Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta lineage thymocytes. Immunity. 16:869-879. doi:10.1016/S1074-7613(02)00330-8
55. Yoon, S.O., X. Zhang, P. Berner, B. Blom, and Y.S. Choi. 2009. Notch ligands expressed by follicular dendritic cells protect germinal center B cells from apoptosis. J. Immunol. 183:352-358. doi:10.4049/jimmunol.0803183
56. Yu, P., M. Kosco-Vilbois, M. Richards, G. Köhler, M.C. Lamers, and G. Kohler. 1994. Negative feedback regulation of IgE synthesis by murine CD23. Nature. 369:753-756. doi:10.1038/369753a0